{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:22:26Z","timestamp":1790270546563,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1925,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2990.2010.01092.x","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T01:29:35Z","timestamp":1274923775000},"page":"388-398","source":"Crossref","is-referenced-by-count":35,"title":["Selective expression and cellular localization of pro-inflammatory chemokine ligand\/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barr\u00e9 syndrome"],"prefix":"10.1111","volume":"36","author":[{"given":"R. H.","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. E.","family":"Ubogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,25]]},"reference":[{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00019052-200210000-00008","article-title":"Acute immunoinflammatory neuropathy: update on Guillain-Barr\u00e9 syndrome","volume":"15","author":"Hartung","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneuro0452","article-title":"From bench to bedside - experimental rationale for immune-specific therapies in the inflamed peripheral nerve","volume":"3","author":"Meyer zu H\u00f6rste","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tips.2005.11.002","article-title":"The expression and function of chemokines involved in CNS inflammation","volume":"27","author":"Ubogu","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cytogfr.2005.05.008","article-title":"Chemokine receptor internalization and intracellular trafficking","volume":"16","author":"Neel","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024532715775","article-title":"Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"Press","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","article-title":"Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10","volume":"125","author":"Kieseier","year":"2002","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-5728(00)00323-4","article-title":"Sequential expression of chemokines in experimental autoimmune neuritis","volume":"110","author":"Kieseier","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0165-5728(02)00393-4","article-title":"Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barre syndrome and experimental autoimmune neuritis","volume":"134","author":"Orlikowski","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(00)00249-6","article-title":"Experimental allergic neuritis in the SJL\/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12","volume":"107","author":"Calida","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2005.07.019","article-title":"Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barr\u00e9 syndrome and experimental allergic neuritis","volume":"168","author":"Nicoletti","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2009.11.019","article-title":"Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barr\u00e9 syndrome","volume":"219","author":"Xia","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mus.21588","article-title":"Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice. Technical aspects and normative data","volume":"41","author":"Xia","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB15|cit15","volume-title":"Electromyography and Neuromuscular Disorders: Clinical and Electrophysiologic Correlations","author":"Preston","year":"2005"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1534\/genetics.108.090894","article-title":"Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse","volume":"180","author":"O'Shea","year":"2008","journal-title":"Genetics"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.4049\/jimmunol.172.7.4556","article-title":"Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL\/J mice through cytokine switch","volume":"172","author":"Huan","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/intimm\/dxh236","article-title":"Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection","volume":"17","author":"Ure","year":"2005","journal-title":"Int Immunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/NEN.0b013e3181c84a9a","article-title":"Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells","volume":"69","author":"Yosef","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB20|cit20","first-page":"60","article-title":"Ulex europaeus I lectin as a marker for vascular endothelium in human tissues","volume":"47","author":"Holth\u00f6fer","year":"1982","journal-title":"Lab Invest"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh655","article-title":"Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis","volume":"129","author":"Mahad","year":"2006","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mus.20893","article-title":"The immunocompetence of Schwann cells","volume":"37","author":"Meyer zu H\u00f6rste","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases","volume":"1173","author":"Lacotte","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2006.06.004","article-title":"Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation","volume":"179","author":"Ubogu","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cellimm.2006.12.001","article-title":"CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro","volume":"243","author":"Ubogu","year":"2006","journal-title":"Cell Immunol"},{"key":"10.1111\/j.1365-2990.2010.01092.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.nbd.2004.04.007","article-title":"CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis","volume":"16","author":"Duan","year":"2004","journal-title":"Neurobiol Dis"}],"container-title":["Neuropathology and Applied Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2990.2010.01092.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2990.2010.01092.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T15:41:37Z","timestamp":1625586097000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2990.2010.01092.x"}},"subtitle":["Chemokines and severe murine EAN"],"short-title":[],"issued":{"date-parts":[[2010,5,25]]},"references-count":27,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01092.x","relation":{},"ISSN":["0305-1846","1365-2990"],"issn-type":[{"value":"0305-1846","type":"print"},{"value":"1365-2990","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,25]]}}}